Top segments and regional performance

Last year, the company generated ‪4.13 B‬ CHF, the most of which — ‪1.22 B‬ CHF — came from its top-performing segment, Injectable Aesthetics - Neuromodulators, compared to ‪1.13 B‬ CHF the previous year. The greatest contribution came from International, which accounted for ‪2.45 B‬ CHF last year, with ‪2.26 B‬ CHF the year before.